lenalidomide has been researched along with Interstitial Nephritis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Alchahin, G; Boncila, SD; Bouaka, C; Fofana, AS; Fongoro, S; Haussaire, D; Samaké, M; Sy, S; Torrents, J; Valensi, RC; Yattara, H | 1 |
Dinh, A; Hogan, JJ; Palmer, MB; Svoboda, J | 1 |
Guron, G; Layne, T; Shaaban, H | 1 |
Izzedine, H; Kheder El-Fekih, R | 1 |
Fine, DM; Holanda, DG; Huff, CA; Lipson, EJ; McDevitt, MA | 1 |
1 review(s) available for lenalidomide and Interstitial Nephritis
Article | Year |
---|---|
[Lenalidomide nephrotoxicity].
Topics: Graft vs Host Disease; Humans; Immunologic Factors; Kidney; Kidney Tubules; Lenalidomide; Necrosis; Nephritis, Interstitial; Prevalence; Renal Insufficiency; Thalidomide | 2016 |
4 other study(ies) available for lenalidomide and Interstitial Nephritis
Article | Year |
---|---|
[A novel cause of acute kidney injury in multiple myeloma: Lenalidomide-induced acute interstitial nephritis].
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Nephritis, Interstitial | 2022 |
Lenalidomide-induced tubulointerstitial nephritis in Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Hodgkin Disease; Humans; Immunohistochemistry; Immunologic Factors; Lenalidomide; Male; Nephritis, Interstitial; Symptom Assessment; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2019 |
A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Drug Hypersensitivity Syndrome; Female; Humans; Lenalidomide; Nephritis, Interstitial; Thalidomide | 2014 |
Lenalidomide-induced acute interstitial nephritis.
Topics: Acute Disease; Antineoplastic Agents; Female; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Nephritis, Interstitial; Thalidomide | 2010 |